Literature DB >> 23411878

Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.

Durga S Borkar1, Suzanne M J Fleiszig, Chelsia Leong, Prajna Lalitha, Muthiah Srinivasan, Avanti A Ghanekar, Connie Tam, Wing Y Li, Michael E Zegans, Stephen D McLeod, Thomas M Lietman, Nisha R Acharya.   

Abstract

OBJECTIVES: To determine whether cytotoxic and invasive Pseudomonas aeruginosa strains differentially influence clinical presentation, outcomes, or therapeutic response in bacterial keratitis.
METHODS: Pseudomonas aeruginosa isolates from the National Eye Institute-funded Steroids for Corneal Ulcers Trial were subtyped as cytotoxic or invasive strains. The main outcome measure compared between the 2 subtypes was change in visual acuity at 3 months using Huber robust regression, adjusting for topical corticosteroid treatment.
RESULTS: Of 101 confirmed P aeruginosa isolates from the Steroids for Corneal Ulcers Trial, 74 had a classically cytotoxic or invasive genotype. While corneal ulcers caused by genotypically invasive P aeruginosa strains were associated at presentation with significantly better visual acuity than corneal ulcers caused by genotypically cytotoxic P aeruginosa strains when adjusting for the effect of ulcer location (P= .008), invasive ulcers had improved significantly less than cytotoxic ulcers at 3 months (0.35; 95% CI, 0.04-0.66 logMAR; P= .03 [3.5-line difference]). Compared with topical moxifloxacin alone, adjunctive treatment with topical corticosteroids was associated with significantly more improvement in visual acuity in the invasive subgroup (P= .04) but was associated with less improvement in visual acuity in the cytotoxic subgroup (P= .07).
CONCLUSIONS: Rational profiling of differentially expressed virulence determinants (eg, cytotoxicity and invasiveness for P aeruginosa) could be used as a tool for decision making in the management of infections to optimize outcomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23411878      PMCID: PMC3796098          DOI: 10.1001/jamaophthalmol.2013.778

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  35 in total

1.  Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).

Authors:  Muthiah Srinivasan; Jeena Mascarenhas; Revathi Rajaraman; Meenakshi Ravindran; Prajna Lalitha; David V Glidden; Kathryn J Ray; Kevin C Hong; Catherine E Oldenburg; Salena M Lee; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2011-10-10

2.  Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors.

Authors:  J A Lomholt; K Poulsen; M Kilian
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Epidemiology of microbial keratitis in southern California. A multivariate analysis.

Authors:  L D Ormerod; E Hertzmark; D S Gomez; R G Stabiner; D J Schanzlin; R E Smith
Journal:  Ophthalmology       Date:  1987-10       Impact factor: 12.079

4.  Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000.

Authors:  Brigitte A Cowell; Barry A Weissman; Karen K Yeung; Larisa Johnson; Sharon Ho; Rajana Van; David Bruckner; Bartly Mondino; Suzanne M J Fleiszig
Journal:  Cornea       Date:  2003-03       Impact factor: 2.651

5.  A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics.

Authors:  Ellen J Lee; Tan N Truong; Myra N Mendoza; Suzanne M J Fleiszig
Journal:  Curr Eye Res       Date:  2003-11       Impact factor: 2.424

6.  Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation.

Authors:  Gita Varaprasathan; Kevin Miller; Thomas Lietman; John P Whitcher; Vicky Cevallos; Masao Okumoto; Todd P Margolis; Miao Yinghui; Emmett T Cunningham
Journal:  Cornea       Date:  2004-05       Impact factor: 2.651

7.  Ulcerative keratitis. Survey of 30 years' laboratory experience.

Authors:  P Asbell; S Stenson
Journal:  Arch Ophthalmol       Date:  1982-01

8.  Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid.

Authors:  Suzanne M J Fleiszig; Mary S F Kwong; David J Evans
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Spectrum of microbial keratitis in South Florida.

Authors:  T J Liesegang; R K Forster
Journal:  Am J Ophthalmol       Date:  1980-07       Impact factor: 5.258

10.  Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model.

Authors:  Ellen J Lee; Brigitte A Cowell; David J Evans; Suzanne M J Fleiszig
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.925

View more
  22 in total

1.  Rose bengal photodynamic antimicrobial therapy to inhibit Pseudomonas aeruginosa keratitis isolates.

Authors:  Heather Durkee; Alejandro Arboleda; Mariela C Aguilar; Jaime D Martinez; Karam A Alawa; Nidhi Relhan; Jorge Maestre-Mesa; Guillermo Amescua; Darlene Miller; Jean-Marie Parel
Journal:  Lasers Med Sci       Date:  2019-12-23       Impact factor: 3.161

2.  Topical Corticosteroids in the Management of Bacterial Keratitis.

Authors:  Sonal S Tuli
Journal:  Curr Ophthalmol Rep       Date:  2013-12

Review 3.  Update on the Management of Infectious Keratitis.

Authors:  Ariana Austin; Tom Lietman; Jennifer Rose-Nussbaumer
Journal:  Ophthalmology       Date:  2017-09-21       Impact factor: 12.079

4.  Distinct susceptibilities of corneal Pseudomonas aeruginosa clinical isolates to neutrophil extracellular trap-mediated immunity.

Authors:  Qiang Shan; Markryan Dwyer; Samir Rahman; Mihaela Gadjeva
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

Review 5.  Use of adjunctive topical corticosteroids in bacterial keratitis.

Authors:  Nina Ni; Muthiah Srinivasan; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman; Jennifer Rose-Nussbaumer
Journal:  Curr Opin Ophthalmol       Date:  2016-07       Impact factor: 3.761

6.  Neutrophil extracellular traps may have a dual role in Pseudomonas aeruginosa keratitis.

Authors:  Binbin Zhu; Lu Zhang; Kelan Yuan; Xiaodan Huang; Renjian Hu; Xiuming Jin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-09-01       Impact factor: 3.267

7.  Impact of topical corticosteroid pretreatment on susceptibility of the injured murine cornea to Pseudomonas aeruginosa colonization and infection.

Authors:  Yvonne T Wu; Tan N Truong; Connie Tam; Myra N Mendoza; Lucia Zhu; David J Evans; Suzanne M J Fleiszig
Journal:  Exp Eye Res       Date:  2018-10-19       Impact factor: 3.467

Review 8.  Contact lens-related corneal infection: Intrinsic resistance and its compromise.

Authors:  Suzanne M J Fleiszig; Abby R Kroken; Vincent Nieto; Melinda R Grosser; Stephanie J Wan; Matteo M E Metruccio; David J Evans
Journal:  Prog Retin Eye Res       Date:  2019-11-20       Impact factor: 21.198

9.  Challenges of corneal infections.

Authors:  L Hazlett; Susmit Suvas; Sharon McClellan; Sandamali Ekanayaka
Journal:  Expert Rev Ophthalmol       Date:  2016-06-30

10.  Cell-type-specific hypertranslocation of effectors by the Pseudomonas aeruginosa type III secretion system.

Authors:  Erin I Armentrout; Emma C Kundracik; Arne Rietsch
Journal:  Mol Microbiol       Date:  2020-11-05       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.